[1] |
Xia C, Dong X, Li H, et al. Cancer statistics in China and United States, 2022: profiles, trends, and determinants[J]. Chin Med J (Engl), 2022, 135(5): 584-590.
|
[2] |
Al-Awsi G, Jasim SA, Fakri Mustafa Y, et al. The role of miRNA-128 in the development and progression of gastrointestinal and urogenital cancer[J]. Future Oncol, 2022, 18(38): 4209-4231.
|
[3] |
Kousar K, Ahmad T, Abduh MS, et al. miRNAs in regulation of tumor microenvironment, chemotherapy resistance, immunotherapy modulation and miRNA therapeutics in cancer[J]. Int J Mol Sci, 2022, 23(22): 13822.
|
[4] |
Calastri M, Ferreira RF, Tenani GD, et al. Investigating VEGF. miR-145-3p, and miR-101-3p expression in patients with cholangiocarcinoma[J]. Asian Pac J Cancer Prev, 2022, 23(7): 2233-2241.
|
[5] |
Zhou L, Mu D, Chen Y. LINC00958 targets miR-145-3p/CDK1 axis to aggravate the malignancy of colon cancer[J]. Ann Clin Lab Sci, 2022, 52(5): 695-706.
|
[6] |
Yang XW, Zhang LJ, Huang XH, et al. miR-145 suppresses cell invasion in hepatocellular carcinoma cells: miR-145 targets ADAM17[J]. Hepatol Res, 2014, 44(5): 551-559.
|
[7] |
Hui AB, Shi W, Boutros PC, et al. Robust global micro-RNA profiling with formalin-fixed paraffin-embedded breast cancer tissues[J]. Lab Invest, 2009, 89(5): 597-606.
|
[8] |
Yu C, Li B, Wang J, et al. miR-145-5p modulates gefitinib resistance by targeting NRAS and MEST in non-small cell lung cancer[J]. Ann Clin Lab Sci, 2021, 51(5): 625-637.
|
[9] |
Liep J, Kilic E, Meyer HA, et al. Cooperative effect of miR-141-3p and miR-145-5p in the regulation of targets in clear cell renal cell carcinoma[J]. PLoS One, 2016, 11(6): e0157801.
|
[10] |
Moon S, Kim DK, Kim J. Apoptosis-related microRNA-145-5p enhances the effects of pheophorbide a-based photodynamic therapy in oral cancer[J]. Oncotarget, 2017, 8(21): 35184-35192.
|
[11] |
Zhou T, Chen S, Mao X. miR-145-5p affects the differentiation of gastric cancer by targeting KLF5 directly[J]. J Cell Physiol, 2019, 234(5): 7634-7644.
|
[12] |
Luo B, Yuan Y, Zhu Y, et al. microRNA-145-5p inhibits prostate cancer bone metastatic by modulating the epithelial-mesenchymal transition[J]. Front Oncol, 2022, 12: 988794.
|
[13] |
Ding B, Fan W, Lou W. hsa_circ_0001955 enhances in vitro proliferation, migration, and invasion of HCC cells through miR-145-5p/NRAS axis[J]. Mol Ther Nucleic Acids, 2020, 22: 445-455.
|
[14] |
Wang S, Wang T, Gu P. microRNA-145-5p inhibits migration, invasion, and metastasis in hepatocellular carcinoma by inhibiting ARF6[J]. Cancer Manag Res, 2021, 13: 3473-3484.
|
[15] |
国家卫生健康委员会. 原发性肝癌诊疗指南(2022年版)[J/CD]. 中华普通外科学文献(电子版), 2022, 16(2): 81-96.
|
[16] |
Bracken CP, Scott HS, Goodall GJ. A network-biology perspective of microRNA function and dysfunction in cancer[J]. Nat Rev Genet, 2016, 17(12): 719-732.
|
[17] |
Liang H, Sun H, Yang J, et al. miR-145-5p reduces proliferation and migration of hepatocellular carcinoma by targeting KLF5[J]. Mol Med Rep, 2018, 17(6): 8332-8338.
|
[18] |
Chen Z, Xu W, Zhang D, et al. circCAMSAP1 promotes osteosarcoma progression and metastasis by sponging miR-145-5p and regulating FLI1 expression[J]. Mol Ther Nucleic Acids, 2020, 23: 1120-1135.
|
[19] |
Gu X, Zhang J, Ran Y, et al. Circular RNA hsa_circ_101555 promotes hepatocellular carcinoma cell proliferation and migration by sponging miR-145-5p and regulating CDCA3 expression[J]. Cell Death Dis, 2021, 12(4): 356.
|
[20] |
Yao Z, Xu R, Yuan L, et al. circ_0001955 facilitates hepatocellular carcinoma (HCC) tumorigenesis by sponging miR-516a-5p to release TRAF6 and MAPK11[J]. Cell Death Dis, 2019, 10(12): 945.
|